CENTENE CORP
NYSE: CNC (Centene Corporation)
Last update: 38 minutes ago29.04
0.66 (2.33%)
Previous Close | 28.38 |
Open | 28.42 |
Volume | 8,171,001 |
Avg. Volume (3M) | 15,080,706 |
Market Cap | 14,262,502,400 |
Price / Earnings (TTM) | 7.05 |
Price / Earnings (Forward) | 14.66 |
Price / Sales | 0.080 |
Price / Book | 0.520 |
52 Weeks Range | |
Earnings Date | 24 Oct 2025 |
Profit Margin | 2.25% |
Operating Margin (TTM) | 4.49% |
Diluted EPS (TTM) | 6.78 |
Quarterly Revenue Growth (YOY) | 16.60% |
Quarterly Earnings Growth (YOY) | 12.70% |
Total Debt/Equity (MRQ) | 65.38% |
Current Ratio (MRQ) | 1.11 |
Operating Cash Flow (TTM) | 2.12 B |
Levered Free Cash Flow (TTM) | 2.51 B |
Return on Assets (TTM) | 3.86% |
Return on Equity (TTM) | 12.53% |
Market Trend
Short Term | Medium Term | ||
Industry | Healthcare Plans (US) | Bearish | Bearish |
Healthcare Plans (Global) | Bearish | Bearish | |
Stock | Centene Corporation | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | -0.5 |
Insider Activity | NA |
Price Volatility | 3.0 |
Technical Moving Averages | -1.0 |
Technical Oscillators | 2.0 |
Average | 0.88 |
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract. |
|
Sector | Healthcare |
Industry | Healthcare Plans |
Investment Style | Mid Value |
% Held by Insiders | 0.46% |
% Held by Institutions | 99.81% |
Ownership
Name | Date | Shares Held |
---|---|---|
Harris Associates L P | 30 Jun 2025 | 20,418,731 |
Aqr Capital Management Llc | 30 Jun 2025 | 8,298,682 |
Politan Capital Management Lp | 30 Jun 2025 | 8,043,255 |
Arrowstreet Capital, Limited Partnership | 30 Jun 2025 | 6,604,382 |
Ameriprise Financial Inc | 30 Jun 2025 | 5,409,000 |
52 Weeks Range | ||
Price Target Range | ||
High | 45.00 (Barclays, 54.96%) | Hold |
Median | 32.00 (10.19%) | |
Low | 28.00 (Baird, -3.58%) | Hold |
28.00 (Morgan Stanley, -3.58%) | Hold | |
Average | 34.25 (17.94%) | |
Total | 2 Buy, 9 Hold, 1 Sell | |
Avg. Price @ Call | 28.49 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Cantor Fitzgerald | 26 Aug 2025 | 38.00 (30.85%) | Hold | 28.66 |
28 Jul 2025 | 38.00 (30.85%) | Hold | 26.86 | |
Morgan Stanley | 04 Aug 2025 | 28.00 (-3.58%) | Hold | 26.21 |
10 Jul 2025 | 33.00 (13.64%) | Hold | 32.52 | |
JP Morgan | 29 Jul 2025 | 30.00 (3.31%) | Hold | 25.53 |
02 Jul 2025 | 48.00 (65.29%) | Hold | 33.78 | |
Oppenheimer | 28 Jul 2025 | 43.00 (48.07%) | Buy | 26.86 |
15 Jul 2025 | 51.00 (75.62%) | Buy | 30.00 | |
Truist Securities | 28 Jul 2025 | 35.00 (20.52%) | Buy | 26.86 |
16 Jul 2025 | 42.00 (44.63%) | Buy | 30.41 | |
UBS | 28 Jul 2025 | 31.00 (6.75%) | Hold | 26.86 |
02 Jul 2025 | 45.00 (54.96%) | Hold | 33.78 | |
Baird | 25 Jul 2025 | 28.00 (-3.58%) | Hold | 28.39 |
Wells Fargo | 23 Jul 2025 | 30.00 (3.31%) | Hold | 29.42 |
TD Cowen | 21 Jul 2025 | 33.00 (13.64%) | Hold | 27.43 |
B of A Securities | 16 Jul 2025 | 30.00 (3.31%) | Sell | 30.41 |
02 Jul 2025 | 52.00 (79.06%) | Hold | 33.78 | |
Mizuho | 11 Jul 2025 | 40.00 (37.74%) | Hold | 31.44 |
Barclays | 02 Jul 2025 | 45.00 (54.96%) | Hold | 33.78 |
02 Jun 2025 | 65.00 (123.83%) | Hold | 54.91 | |
Show more |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |